ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 39 of 153 for:    cannabis | Recruiting, Enrolling by invitation Studies

Intracranial Arterial Stenosis and Resin of Cannabis Use

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02246140
Recruitment Status : Recruiting
First Posted : September 22, 2014
Last Update Posted : September 8, 2017
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

September 17, 2014
September 22, 2014
September 8, 2017
July 2014
December 2019   (Final data collection date for primary outcome measure)
Presence of intracranial arterial stenosis on cerebral MRA [ Time Frame: 3 months ]
Rate on cerebral MRA the presence of cerebral Intracranial Arterial Stenosis segmental narrowing defined by at least two intra-cranial arteries compared with a cohort of non cannabis controls subjects.
Same as current
Complete list of historical versions of study NCT02246140 on ClinicalTrials.gov Archive Site
  • -Silent ischemic stroke on cerebral MRI [ Time Frame: 3 months ]
    Evaluate on cerebral MRI the presence of sequelae of ischemic stroke defined by a parenchymal hyperintensity in a vascular territory defined on a T2 sequence.
  • -new intracranial arterial stenosis at 3 month follow-up [ Time Frame: 3 months ]
    Evaluate a cerebral MRA at 3 months the presence of new intracranial stenosis among cannabis users, according to the prosecution or stopping use
  • -Reversibility of intracranial arterial stenosis at 3 month follow-up [ Time Frame: 3 months ]
    Evaluate on cerebral MRA at 3 months reversibility stenosis present at T0 in cannabis users having stopped their consumption
Same as current
Not Provided
Not Provided
 
Intracranial Arterial Stenosis and Resin of Cannabis Use
Prevalence of Intracranial Arterial Stenosis in Regular Resin of Cannabis Users Compared to Control Subjects: a Preliminary Study of Feasibility
There is an association between intracranial arterial stenosis and ischemic stroke in young adults. The aim of this study is to evaluate the prevalence of intracranial arterial stenosis in asymptomatic regular resin of cannabis users in comparison with control subjects.
Not Provided
Interventional
Not Applicable
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Cannabis Users
Other: Cerebral MRI and MRA
  • Experimental: Cannabis users
    Cerebral MRI and MRA
    Intervention: Other: Cerebral MRI and MRA
  • Active Comparator: healthy volunteers
    Cerebral MRI and MRA
    Intervention: Other: Cerebral MRI and MRA
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
60
Same as current
December 2019
December 2019   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • regular resin of cannabis users

Exclusion Criteria:

  • taking vasoactive medications
  • taking other illicit drugs
Sexes Eligible for Study: All
18 Years to 45 Years   (Adult)
Yes
Contact: Valerie Wolff, MD 03 88 12 86 06 ext 0033 valerie.wolff@chru-strasbourg.fr
France
 
 
NCT02246140
5715
No
Not Provided
Not Provided
University Hospital, Strasbourg, France
University Hospital, Strasbourg, France
Not Provided
Principal Investigator: Valerie Wolff, MD University Hospital, Strasbourg, France
University Hospital, Strasbourg, France
September 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP